• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路上皮癌中细胞角蛋白和细胞外胶原表达的预后价值。

The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer.

机构信息

Institute of Pathology, Faculty of Medicine, University of Duisburg-Essen, 45147 Essen, Germany.

Department of Urology, Semmelweis University, 1082 Budapest, Hungary.

出版信息

Curr Mol Med. 2022;22(10):941-949. doi: 10.2174/1566524021666210225100041.

DOI:10.2174/1566524021666210225100041
PMID:33632097
Abstract

BACKGROUND

Expression levels of collagens have been implicated in the progression of various cancers and interaction with cytokeratins but are not well studied in bladder cancer (BC). Therefore, we analyzed the gene and protein expression levels of collagen 1A1 (Col1a1/COL1A1), collagen 3A1 (col3a1/COL3A1), collagen 5A2 (col5a2/COL5A2), cytokeratin 14 (krt14/CK14), and cytokeratin 17 (krt17/CK17) in urothelial BC samples of different stages.

METHODS

In total, 102 fresh frozen and 190 formalin-fixed and paraffin-embedded (FFPE) samples were tested using immunohistochemistry and RT-qPCR. Expression levels were correlated with clinicopathological and follow-up data.

RESULTS

Col1a1, col3a1, col5a2 and krt14 mRNA levels were significantly overexpressed in high-grade and muscle-invasive BC (MIBC) compared to low-grade and non-muscle invasive BC (NMIBC) cases. Disease-specific survival (DSS) was shorter in patients with high expression levels of col1a1 (p = 0.004), col3a1 (p = 0.004), and col5a2 (p = 0.028). CK14 (p = 0.020), COL3A1 (p = 0.006), and Col5A2 (p = 0.006) protein expression levels were significantly higher and protein expression levels of CK17 (p = 0.05) were significantly lower in MIBC compared to NMIBC. Furthermore, CK14 (p = 0.002) and COL5A2 (p = 0.006) protein expression level were significantly higher in high-grade compared to low-grade BC. DSS was shorter in patients with high expression levels of COL5A2 (p = 0.033) and CK14 (p = 0.042).

CONCLUSION

Expression changes of collagens and cytokeratins are univariable prognostic markers in BC.

摘要

背景

胶原蛋白的表达水平与各种癌症的进展有关,与细胞角蛋白相互作用,但在膀胱癌(BC)中研究甚少。因此,我们分析了不同分期的尿路上皮 BC 样本中胶原蛋白 1A1(Col1a1/COL1A1)、胶原蛋白 3A1(col3a1/COL3A1)、胶原蛋白 5A2(col5a2/COL5A2)、细胞角蛋白 14(krt14/CK14)和细胞角蛋白 17(krt17/CK17)的基因和蛋白表达水平。

方法

共检测了 102 例新鲜冷冻和 190 例福尔马林固定石蜡包埋(FFPE)样本,采用免疫组化和 RT-qPCR 进行检测。表达水平与临床病理和随访数据相关。

结果

与低级别和非肌层浸润性 BC(NMIBC)相比,高级别和肌层浸润性 BC(MIBC)中 Col1a1、col3a1、col5a2 和 krt14 mRNA 水平明显过表达。Col1a1(p = 0.004)、col3a1(p = 0.004)和 col5a2(p = 0.028)高表达患者的疾病特异性生存率(DSS)更短。与 NMIBC 相比,MIBC 中 CK14(p = 0.020)、COL3A1(p = 0.006)和 Col5A2(p = 0.006)蛋白表达水平显著升高,CK17 蛋白表达水平(p = 0.05)显著降低。此外,高级别 BC 中 CK14(p = 0.002)和 COL5A2(p = 0.006)蛋白表达水平明显高于低级别 BC。COL5A2(p = 0.033)和 CK14(p = 0.042)高表达患者的 DSS 更短。

结论

胶原蛋白和细胞角蛋白的表达变化是 BC 的单变量预后标志物。

相似文献

1
The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder Cancer.尿路上皮癌中细胞角蛋白和细胞外胶原表达的预后价值。
Curr Mol Med. 2022;22(10):941-949. doi: 10.2174/1566524021666210225100041.
2
Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma.生物信息学鉴定肌层浸润性膀胱癌中的潜在枢纽基因。
Cell Transplant. 2020 Jan-Dec;29:963689720965178. doi: 10.1177/0963689720965178.
3
Prognostic stratification of muscle invasive urothelial carcinomas using limited immunohistochemical panel of Gata3 and cytokeratins 5/6, 14 and 20.使用 Gata3 及细胞角蛋白 5/6、14 和 20 的有限免疫组织化学组合对肌层浸润性尿路上皮癌进行预后分层。
Ann Diagn Pathol. 2019 Dec;43:151397. doi: 10.1016/j.anndiagpath.2019.08.001. Epub 2019 Aug 3.
4
Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.中心体蛋白55(CEP55)在人膀胱移行细胞癌中的表达及临床意义
Immunobiology. 2015 Jan;220(1):103-8. doi: 10.1016/j.imbio.2014.08.014. Epub 2014 Aug 21.
5
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.在pT1期非肌层浸润性膀胱癌(NMIBC)中,高KRT20和低KRT5 mRNA表达可识别管腔亚型,并预测复发和生存情况。
Virchows Arch. 2017 Mar;470(3):267-274. doi: 10.1007/s00428-017-2064-8. Epub 2017 Jan 10.
6
Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.钙调蛋白的过表达与原发性非肌层浸润性膀胱癌患者的肿瘤进展相关。
Oncotarget. 2015 Nov 24;6(37):40370-84. doi: 10.18632/oncotarget.5458.
7
Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.膀胱尿路上皮癌患者的上皮-间质转化及其与临床病理特征的相关性
Clin Genitourin Cancer. 2017 Apr;15(2):e187-e197. doi: 10.1016/j.clgc.2016.07.021. Epub 2016 Aug 9.
8
Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.基于加权基因共表达网络分析鉴定肌肉浸润性膀胱癌的潜在预后标志物。
Pathol Oncol Res. 2020 Apr;26(2):1063-1072. doi: 10.1007/s12253-019-00657-6. Epub 2019 Apr 22.
9
Predicting progression of bladder urothelial carcinoma using microRNA expression.利用 microRNA 表达预测膀胱尿路上皮癌的进展。
BJU Int. 2013 Nov;112(7):1027-34. doi: 10.1111/j.1464-410X.2012.11748.x. Epub 2013 Feb 6.
10
Prognostic DNA Methylation Biomarkers in High-risk Non-muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation.高危非肌肉浸润性膀胱癌预后 DNA 甲基化生物标志物:前瞻性验证的候选基因的系统评价
Eur Urol Focus. 2020 Jul 15;6(4):683-697. doi: 10.1016/j.euf.2019.02.012. Epub 2019 Feb 23.

引用本文的文献

1
Targeting collagen to optimize cancer immunotherapy.靶向胶原蛋白以优化癌症免疫疗法。
Exp Hematol Oncol. 2025 Jul 29;14(1):101. doi: 10.1186/s40164-025-00691-y.
2
Integrative multi-omics study identifies sex-specific molecular signatures and immune modulation in bladder cancer.整合多组学研究确定了膀胱癌中性别特异性分子特征和免疫调节。
Front Bioinform. 2025 May 19;5:1575790. doi: 10.3389/fbinf.2025.1575790. eCollection 2025.
3
Downregulation of the keratins CK13 and CK14 does not significantly affect cell viability of human urinary bladder carcinoma cells.
角蛋白CK13和CK14的下调对人膀胱癌细胞的细胞活力没有显著影响。
Contemp Oncol (Pozn). 2024;28(3):227-234. doi: 10.5114/wo.2024.144215. Epub 2024 Oct 15.
4
Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts.Hic-5调节癌症相关成纤维细胞中细胞外基质相关基因的表达和细胞因子的分泌。
Exp Cell Res. 2024 Feb 15;435(2):113930. doi: 10.1016/j.yexcr.2024.113930. Epub 2024 Jan 17.
5
Clinical utility of keratin 14 expression measurement in reflecting the tumor properties and prognosis in patients with renal cell carcinoma: a study with long-term follow-up.角蛋白 14 表达测量在反映肾细胞癌患者肿瘤特性和预后中的临床实用性:一项具有长期随访的研究。
Int Urol Nephrol. 2024 Jun;56(6):2045-2053. doi: 10.1007/s11255-023-03923-4. Epub 2024 Jan 11.
6
Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.HPV 相关与非 HPV 相关人类癌症中应激角蛋白 17 的预后和预测意义的新进展:范围综述。
Viruses. 2023 Nov 25;15(12):2320. doi: 10.3390/v15122320.
7
Evaluation of IGF2, KRT14, and KRT20 as Urinary Biomarkers in Patients with Bladder Cancer.评估IGF2、KRT14和KRT20作为膀胱癌患者尿液生物标志物的情况。
Rep Biochem Mol Biol. 2023 Jan;11(4):710-719. doi: 10.52547/rbmb.11.4.710.
8
Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm.基于逻辑回归和支持向量机算法的增强CT图像组学模型在膀胱癌HRG无创预测中的构建及预后价值
Front Oncol. 2023 Jan 16;12:966506. doi: 10.3389/fonc.2022.966506. eCollection 2022.
9
An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer.用于鉴定膀胱癌诊断、预后和预测关键生物标志物的综合生物信息学分析
Cancers (Basel). 2022 Jul 10;14(14):3358. doi: 10.3390/cancers14143358.